ANI Pharmaceuticals, Inc.
ANIP
$97.10
$1.902.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.21M | -21.05M | -18.52M | -7.09M | 27.02M |
| Total Depreciation and Amortization | 84.52M | 75.94M | 67.73M | 60.33M | 59.78M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.72M | 25.48M | 25.99M | 15.04M | 7.16M |
| Change in Net Operating Assets | 41.11M | 369.00K | -11.19M | 24.62M | 18.63M |
| Cash from Operations | 139.14M | 80.74M | 64.02M | 92.90M | 112.59M |
| Capital Expenditure | -13.69M | -14.13M | -16.24M | -16.12M | -13.05M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 13.51M | 13.51M | 13.51M |
| Cash Acquisitions | -401.28M | -401.28M | -401.28M | -393.08M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.98M | -18.09M | -717.00K | -3.13M | -5.31M |
| Cash from Investing | -435.96M | -433.50M | -404.72M | -398.82M | -4.85M |
| Total Debt Issued | 641.25M | 641.25M | 641.25M | 641.25M | -- |
| Total Debt Repaid | -298.59M | -297.31M | -296.03M | -296.63M | -3.00M |
| Issuance of Common Stock | 6.67M | 6.43M | 6.49M | 6.76M | 11.15M |
| Repurchase of Common Stock | -11.55M | -12.30M | -10.96M | -10.87M | -10.86M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M |
| Other Financing Activities | -61.68M | -61.68M | -74.18M | -80.95M | -25.00M |
| Cash from Financing | 274.47M | 274.77M | 264.95M | 257.93M | -29.34M |
| Foreign Exchange rate Adjustments | 74.00K | -767.00K | -470.00K | -75.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.28M | -78.76M | -76.23M | -48.06M | 78.40M |